Search results
Results from the WOW.Com Content Network
Adult Attention Deficit Hyperactivity Disorder is the persistence of attention deficit hyperactivity disorder (ADHD) into adulthood. It is a neurodevelopmental disorder, meaning impairing symptoms must have been present in childhood, except for when ADHD occurs after traumatic brain injury. [ 1][ 2][ 3] Specifically, multiple symptoms must be ...
In 1987, this was changed to ADHD in the DSM-III-R, and in 1994 the DSM-IV in split the diagnosis into three subtypes: ADHD inattentive type, ADHD hyperactive-impulsive type, and ADHD combined type. [343] These terms were kept in the DSM-5 in 2013 and in the DSM-5-TR in 2022. [3] [4] Prior to the DSM, terms included minimal brain damage in the ...
The DSM-5 allows for diagnosis of the predominantly inattentive presentations of ADHD (ICD-10 code F90.0) if the individual presents six or more (five for adults) of the following symptoms of inattention for at least six months to a point that is disruptive and inappropriate for developmental level:
Dulaglutide, sold under the brand name Trulicity among others, [6] is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. [7] [8] It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors. [9]
Atomoxetine. Atomoxetine, sold under the brand name Strattera, is a selective norepinephrine reuptake inhibitor medication used to treat attention deficit hyperactivity disorder (ADHD) [ 12] and, to a lesser extent, cognitive disengagement syndrome. [ 13][ 14][ 15] It may be used alone or along with psychostimulants. [ 16][ 17] It enhances the ...
However, with the publication of DSM-5 in 2013, ADHD continues to be classified as predominantly inattentive, predominantly hyperactive-impulsive, and combined type and there continues to be no mention of CDS as a diagnosis or a diagnosis subtype anywhere in the manual.
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD. The American Academy of Pediatrics (AAP) recommends different treatment paradigms depending on the age of the person being treated. For those aged 4–5, the AAP recommends evidence-based parent- and/or teacher ...
Endocrinology. Symptoms. Lack of appetite, nausea, vomiting, abdominal pain, seizures and coma [ 1] The syndrome of inappropriate antidiuretic hormone secretion ( SIADH ), also known as the syndrome of inappropriate antidiuresis ( SIAD ), [ 2] is characterized by a physiologically inappropriate release of antidiuretic hormone (ADH) either from ...